Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Express Scripts
Mallinckrodt
AstraZeneca
Healthtrust
Harvard Business School
Julphar
Baxter

Generated: November 13, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Refametinib

« Back to Dashboard

US Patents for Refametinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Refametinib ➤ Try a Free Trial Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK Ardea Biosciences (San Diego, CA) ➤ Try a Free Trial
Refametinib ➤ Try a Free Trial Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof Ardea Biosciences Inc. (San Diego, CA) ➤ Try a Free Trial
Refametinib ➤ Try a Free Trial Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK Ardea Biosciences (Costa Mesa, CA) ➤ Try a Free Trial
Refametinib ➤ Try a Free Trial Compounds and compositions as protein kinase inhibitors Novartis AG (Basel, CH) ➤ Try a Free Trial
Refametinib ➤ Try a Free Trial Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof Ardea Biosciences, Inc. (San Diego, CA) ➤ Try a Free Trial
Refametinib ➤ Try a Free Trial Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof Ardea Biosciences, Inc. (San Diego, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Refametinib

Drugname Country Document Number Estimated Expiration Related US Patent
Refametinib African Regional IP Organization (ARIPO) 2817 2025-07-21 ➤ Try a Free Trial
Refametinib Austria 483463 2025-07-21 ➤ Try a Free Trial
Refametinib Australia 2006272837 2025-07-21 ➤ Try a Free Trial
Refametinib Australia 2007237901 2025-07-21 ➤ Try a Free Trial
Refametinib Australia 2008206045 2025-07-21 ➤ Try a Free Trial
Refametinib Australia 2008282338 2025-07-21 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Express Scripts
Healthtrust
Moodys
Mallinckrodt
Teva
AstraZeneca
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.